"Antibody Specificity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
- Antibody Specificity
- Antibody Specificities
- Specificities, Antibody
- Specificity, Antibody
Below are MeSH descriptors whose meaning is more general than "Antibody Specificity".
Below are MeSH descriptors whose meaning is more specific than "Antibody Specificity".
This graph shows the total number of publications written about "Antibody Specificity" by people in this website by year, and whether "Antibody Specificity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Antibody Specificity" by people in Profiles.
Janech MG, Rodgers JL, Arthur JM, Velez JC. Letter to the editor: "Concern regarding quantification of urinary nephrin by a commercially available ELISA". Am J Physiol Renal Physiol. 2015 Aug 01; 309(3):F269-70.
Kulik L, Hewitt FB, Willis VC, Rodriguez R, Tomlinson S, Holers VM. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease. Mol Immunol. 2015 Feb; 63(2):479-88.
Bruner BF, Guthridge JM, Lu R, Vidal G, Kelly JA, Robertson JM, Kamen DL, Gilkeson GS, Neas BR, Reichlin M, Scofield RH, Harley JB, James JA. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis Rheum. 2012 Nov; 64(11):3677-86.
Pandey JP. Comment on "Flagellin as an adjuvant: cellular mechanisms and potential". J Immunol. 2011 Feb 01; 186(3):1299; author reply 1299.
Argraves WS, Tanaka A, Smith EP, Twal WO, Argraves KM, Fan D, Haudenschild CC. Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem Cell Biol. 2009 Nov; 132(5):559-65.
Wise SK, Ahn CN, Schlosser RJ. Localized immunoglobulin E expression in allergic rhinitis and nasal polyposis. Curr Opin Otolaryngol Head Neck Surg. 2009 Jun; 17(3):216-22.
Rehtanz M, Bossart GD, Doescher B, Rector A, Van Ranst M, Fair PA, Jenson AB, Ghim SJ. Bottlenose dolphin (Tursiops truncatus) papillomaviruses: vaccine antigen candidates and screening test development. Vet Microbiol. 2009 Jan 01; 133(1-2):43-53.
Sambamurti K, Pappolla MA, Jagannatha Rao KS. Value in development of a TAPIR-like mouse monoclonal antibody to Abeta. J Alzheimers Dis. 2008 Jun; 14(2):175-7.
Jaskowski TD, Prince HE, Greer RW, Litwin CM, Hill HR. Further comparisons of assays for detecting MAG IgM autoantibodies. J Neuroimmunol. 2007 Jul; 187(1-2):175-8.
Dolloff NG, Russell MR, Loizos N, Fatatis A. Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor. Cancer Res. 2007 Jan 15; 67(2):555-62.